Prostate Cancer Clinical Trials in Michigan

Showing 141-160 of 329 trials

Genomics in Michigan Impacting Observation or Radiation

NCT02783950

To determine the impact of Decipher test results on adjuvant treatment decisions of high-risk post-RP patients with undetectable post-op prostate specific antigen (PSA) compared to clinical factors alone.

Prostate Cancer

University of Michigan Rogel Cancer Center356 participantsStarted Jan 2017

Ann Arbor, Michigan, United States • Detroit, Michigan, United States • Detroit, Michigan, United States +10 more locations

COMPLETED41 miles

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

NCT02380274

The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.

Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer

Astellas Pharma Global Development, Inc.1,030 participantsStarted Mar 2015

Homewood, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +145 more locations

Genomics in Michigan Impacting Observation or Radiation

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Prostate Cancer Trials in Other Cities

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

Prostate Imaging Using MRI +/- Contrast Enhancement

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

Other Conditions in Michigan